Trials / Completed
CompletedNCT03686059
Outcome of Omega 3 FA and Punctal Plugs on Ocular Surface Disease
Outcome of Concomitant Use of Punctal Plugs and Omeg 3 Fatty Acids on Ocular Surface Disease in Patients Using Systemic Isotretinoin
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 90 (actual)
- Sponsor
- Benha University · Academic / Other
- Sex
- All
- Age
- 18 Years – 40 Years
- Healthy volunteers
- Not accepted
Summary
Ocular surface disease is a common adverse effect of systemic isotretinoin therapy. The investigators consider that punctal plugs and Omega 3 is a good line for treatment of ocular surface disease associated with systemic isotretinoin therapy
Detailed description
Subjective and objective evaluation of ocular surface disease was done at baseline ,1 and 3 months of the study .
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Omega 3 | daily intake of 250 mg |
| DEVICE | punctal plug | punctal plug will be inserted in inferior punctum |
Timeline
- Start date
- 2018-07-02
- Primary completion
- 2019-11-15
- Completion
- 2019-11-20
- First posted
- 2018-09-26
- Last updated
- 2019-11-26
Locations
1 site across 1 country: United Arab Emirates
Source: ClinicalTrials.gov record NCT03686059. Inclusion in this directory is not an endorsement.